Scientists develop energy saving technique paving way for a carbon neutral society
2021-06-21
(Press-News.org) Researchers at the University of Bristol have discovered a method which will allow for faster communication systems and better energy saving electronics.
The breakthrough was made by establishing how to remotely measure the electric field inside a semiconductor device for the first time. A semiconductor is a material, such as Silicon, which can be used in electronic devices to control electric current.
Now, in this new study, published today in Nature Electronics, scientists outline how to precisely quantify this electric field, meaning next generation power and radio frequency electronic devices can be developed which have the potential to be faster, and more reliable, as well as more energy efficient.
Semiconductor device design can be trial and error, though more commonly it is based on a device simulation which then provides the basis for the manufacture of the semiconductor devices for real life applications. When these are new and emerging semiconductor materials, it has often been unknown how accurate and correct these simulations actually are.
Prof Martin Kuball of the University of Bristol's School of Physics said: "Semiconductors can be made to conduct positive or negative charges and can therefore be designed to modulate and manipulate current. However, these semiconductor devices do not stop with Silicon, there are many others including Gallium Nitride (used in blue LEDs for example). These semiconductor devices, which for instance convert an AC current from a power line into a DC current, result in a loss of energy as waste heat - look at your laptop for example, the power brick is getting warm or even hot. If we could improve efficiency and reduce this waste heat, we will save energy.
"One applies a voltage to an electronic device, and as a result there is an output current used in the application. Inside this electronic device is an electric field which determines how this device works and how long it will be operational and how good its operation is. No one could actually measure this electric field, so fundamental to the device operation. One always relied on simulation which is hard to trust unless you can actually test its accuracy."
To make good performance and long lasting electronic devices out of these new materials it is important that researchers find the optimal design, where electric fields do not exceed the critical value which would result in their degradation or failure. Experts plan to use newly emerging materials such as Gallium Nitride and Gallium Oxide rather than Silicon, allowing operation at higher frequency and at higher voltages, respectively, so that new circuits are possible which reduce energy loss. This work published by the University of Bristol group will provide an optical tool to enable the direct measurement of electric field within these new devices. This will underpin future efficient power electronics in applications such as solar or wind turbine stations feeding into the national grid, electric cars, trains and planes. Reduced energy loss means societies do not need to produce as much energy in the first place.
Prof Kuball said: "Considering that these devices are operated at higher voltages, this also means electric fields in the devices are higher and this in turn means they can fail easier. The new technique we have developed enables us to quantify electric fields within the devices, allowing accurate calibration of the device simulations that in turn design the electronic devices so the electric fields do not exceed critical limits and fail."
Prof Kuball and his team plan to work with key industrial stake holders to apply the technique to advance their device technology. Within an academic context, they will engage with partners within the $12M US Department of Energy (DOE) ULTRA centre, they are partnered in, to use this technique to make ultra-wide bandgap device technology a reality, allowing energy savings in excess of 10% across the globe.
"This development helps the UK and the world to develop energy saving semiconductor devices, which is a step towards a carbon neutral society," he added.
The technique was developed as part of an Engineering and Physical Sciences Research Council (EPSRC) project.
INFORMATION:
Paper
'Electric field mapping of wide-bandgap semiconductor devices at a submicrometre resolution' in Nature Electronics by Martin Kuball, Yuke Cao, James W Pomeroy, Michael J Uren and Feiyuan Yang
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
2021-06-21
A process using a light-sensitive chemical can drastically reduce cost and energy consumption to produce gamma-cyclodextrin, a compound that is widely used in manufacturing, according to a Dartmouth study.
The research, published in Chem, demonstrates how a hydrazone template can replace energy-intensive distillation to produce and isolate gamma-cyclodextrin--a water-soluble chemical that attracts other molecules and is used to enhance food, pharmaceuticals, and a wide range of consumer products.
"These compounds are biodegradable, biocompatible, benign and commonly used," said Ivan Aprahamian, a professor of chemistry at Dartmouth. "We are making ...
2021-06-21
By the time people with Alzheimer's disease start exhibiting difficulty remembering and thinking, the disease has been developing in their brains for two decades or more, and their brain tissue already has sustained damage. As the disease progresses, the damage accumulates, and their symptoms worsen.
Researchers at Washington University School of Medicine in St. Louis have found that high levels of a normal protein associated with reduced heart disease also protect against Alzheimer's-like brain damage - at least in mice. The findings, published June 21 in Neuron, suggest that raising levels ...
2021-06-21
An investigational Alzheimer's drug reduced molecular markers of disease and curbed neurodegeneration in the brain, without demonstrating evidence of cognitive benefit, in a phase 2/3 clinical trial led by researchers at Washington University School of Medicine in St. Louis through its Dominantly Inherited Alzheimer Network-Trials Unit (DIAN-TU). These results led the trial leaders to offer the drug, known as gantenerumab, to participants as part of an exploratory open-label extension. The researchers continue to monitor changes in measures of Alzheimer's disease in those participants who are receiving the drug.
The DIAN-TU study (ClinicalTrials.gov Identifier: NCT01760005), published June 21 in Nature Medicine, evaluated the effects of two investigational drugs - ...
2021-06-21
In the mid-2030s, multiple United States coastal regions may see rapid increases in the number of high-tide flooding (HTF) days, according to a study led by the University of Hawai'i at Mānoa and published today in Nature Climate Change. The combined effects of sea-level rise (SLR) and natural fluctuations in tidal range are anticipated to cause tipping points in the frequency of HTF.
Coastal locations around the U.S., particularly along the Atlantic coast, are experiencing recurrent flooding at high tide. The impact of HTF accumulates over numerous seemingly minor occurrences, which can exceed the impact of rare extremes over time. These impacts are subtle--for example, the loss of revenue due to recurrent road and business closures--compared with the physical damage of property ...
2021-06-21
Scientists studying a common childhood cancer have made a major breakthrough which could lead to a cure for some youngsters who would not have survived the condition.
An international study, involving Newcastle University, UK, has for the first time found a genetic marker in tumours from patients with high-risk neuroblastoma.
Research, published in the Journal of Clinical Oncology, has identified that alterations in the neuroblastoma's ALK (anaplastic lymphoma kinase) gene are associated with a significantly poorer prognosis for children with high-risk disease.
Experts ...
2021-06-21
Drugs routinely used during fertility treatments to release eggs do not increase the risk of developing breast cancer, new research has shown.
Researchers from King's College London, in partnership with King's Fertility, analysed studies involving 1.8 million women undergoing fertility treatments. These women were followed up in studies for an average period of 27 years and had no increase in the risk of developing breast cancer.
The research, published today in Fertility and Sterility journal, is the largest study to date assessing whether commonly used fertility drugs are for a cancer risk for women.
Fertility treatments can range from using medications to boost the release of an egg in a women's natural cycle to more complex ...
2021-06-21
A study by the University of Liverpool has shown that while asymptomatic COVID-19 testing in Liverpool was popular, significant inequalities were evident between those who got tested and those who didn't.
Published in the journal The Lancet Regional Health - Europe, the study found that 43% of residents aged over 5 years (n = 214 525) took up the offer of free testing for people without symptoms of COVID-19 between 6th November 2020 and 31st January 2021. A total of 1.3% of tests were positive, meaning that 5192 individuals who did not know they had the virus were notified ...
2021-06-21
The avian influenza, an acute viral infectious disease that occurs in poultry such as chickens, ducks, and migratory birds, has been reported to be transmittable to humans. It is difficult to control because it spreads among migratory birds that travel to China, Europe, and elsewhere. Once it is transmitted, it spreads rapidly. Disposing infected livestock is not only costly, but also a cause of serious environmental pollution. This is why vaccines against infectious diseases are imperative. To this, a research team in Korea has recently developed a plant-based, adjuvant-free, recombinant protein vaccine that exhibits a strong immune response.
Professor ...
2021-06-21
Researchers from the German Center for Infection Research (DZIF) at Charité - Universitätsmedizin Berlin and the University of Bonn have examined the way in which SARS-CoV-2 reprograms the metabolism of the host cell in order to gain an overall advantage. According to their report in Nature Communications*, the researchers were able to identify four substances which inhibit SARS-CoV-2 replication in the host cell: spermine and spermidine, substances naturally found in the body; MK-2206, an experimental cancer drug; and niclosamide, a tapeworm drug. Charité is currently conducting a trial to determine whether niclosamide is also effective against COVID-19 in humans.
Viral replication depends on host cell machinery and ...
2021-06-21
A blood test that can detect tiny amounts of circulating cancer DNA may be able to identify risk of cancer recurrence and guide precision treatment in bladder cancer following surgery, according to a clinical study led by Professor Tom Powles from Queen Mary University of London and Barts Health NHS Trust. The findings from the study, published in Nature, may change our understanding of cancer care following surgery.
The study found that patients with urothelial cancer who had a particular cancer DNA marker in their blood following surgery to remove their tumour had a higher likelihood of cancer relapse. These patients could benefit from subsequent treatment with an immunotherapy called atezolizumab.
Globally, ...
LAST 30 PRESS RELEASES:
[Press-News.org] Scientists develop energy saving technique paving way for a carbon neutral society